Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.
Kaur G. et al, (2022), Nat Commun, 13
Identification of early neurodegenerative pathways in progressive multiple sclerosis.
Kaufmann M. et al, (2022), Nat Neurosci
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.
Kaufmann M. et al, (2021), Med (N Y), 2, 296 - 312.e8
Structural and regulatory diversity shape HLA-C protein expression levels.
Kaur G. et al, (2017), Nat Commun, 8
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.
Dendrou CA. et al, (2016), Sci Transl Med, 8
Natural killer cells and their receptors in multiple sclerosis.
Kaur G. et al, (2013), Brain, 136, 2657 - 2676
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Gregory AP. et al, (2012), Nature, 488, 508 - 511
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Kaur G. et al, (2010), Mol Immunol, 48, 321 - 332
The role of Foxp3 in regulatory T cell differentiation and function
Kaur G. et al, (2009), Current Immunology Reviews, 5, 89 - 101
A role of cellular prion protein in programming T-cell cytokine responses in disease.
Ingram RJ. et al, (2009), FASEB J, 23, 1672 - 1684
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells.
Isaacs JD. et al, (2008), Immunology, 125, 313 - 319
CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC. et al, (2007), Immunology, 121, 129 - 139